No interaction studies have been conducted with avelumab.
Avelumab is primarily metabolised through catabolic pathways, therefore, it is not expected that avelumab will have pharmacokinetic drug-drug interactions with other medicinal products.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.